Citation: R. Li et al., Determination of glycerol in plasma by an automated enzymatic spectrophotometric procedure, CLIN CH L M, 39(1), 2001, pp. 20-24
Authors:
Fisher, AL
DePuy, E
Shih, T
Stearns, R
Lee, Y
Gottesdiener, K
Flattery, S
De Smet, M
Keymeulen, B
Musson, DG
Citation: Al. Fisher et al., Liquid chromatographic-tandem mass spectrometric urine assay for a highly metabolized cyclic ureidobenzenesulfonamide: issues concerning assay specificity and quality control preparation, J PHARM B, 26(5-6), 2001, pp. 739-752
Authors:
Weets, I
Van Autreve, J
Van der Anwera, BJ
Schuit, FC
Du Caju, MVL
Decochez, K
De Leeuw, IH
Keymeulen, B
Mathieu, C
Rottiers, R
Dorchy, H
Quartier, E
Gorus, FK
Citation: I. Weets et al., Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: possible relation to increased body mass index, DIABETOLOG, 44(1), 2001, pp. 40-47
Authors:
Decochez, K
Keymeulen, B
Somers, G
Dorchy, H
De Leeuw, IH
Mathieu, C
Rottiers, R
Winnock, F
ver Elst, K
Weets, I
Kaufman, L
Pipeleers, DG
Gorus, FK
Citation: K. Decochez et al., Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset, DIABET CARE, 23(8), 2000, pp. 1072-1078
Authors:
Schwartz, JI
Bugianesi, KJ
Ebel, DL
De Smet, M
Haesen, R
Larson, PJ
Ko, A
Verbesselt, R
Hunt, TL
Lins, R
Lens, S
Porras, AG
Dieck, J
Keymeulen, B
Gertz, BJ
Citation: Ji. Schwartz et al., The effect of rofecoxib on the pharmacodynamics and pharmacokinetics of warfarin, CLIN PHARM, 68(6), 2000, pp. 626-636
Authors:
Lee, Y
Conroy, JA
Stepanavage, ME
Mendel, CM
Somers, G
McLoughlin, DA
Olah, TV
De Smet, M
Keymeulen, B
Rogers, JD
Citation: Y. Lee et al., Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers, BR J CL PH, 47(4), 1999, pp. 373-378
Authors:
Stobbe, I
Duinkerken, G
van Rood, JJ
Lernmark, A
Keymeulen, B
Pipeleers, D
De Vries, RRP
Claas, FHJ
Roep, BO
Citation: I. Stobbe et al., Tolerance to kidney allograft transplanted into Type I diabetic patients persists after in vivo challenge with pancreatic islet allografts that express repeated mismatches, DIABETOLOG, 42(11), 1999, pp. 1379-1380
Authors:
Roep, BO
Stobbe, I
Duinkerken, G
van Rood, JJ
Lernmark, A
Keymeulen, B
Pipeleers, D
Claas, FHJ
de Vries, RRP
Citation: Bo. Roep et al., Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients, DIABETES, 48(3), 1999, pp. 484-490
Authors:
Bex, M
Buysschaert, M
De Leeuw, I
De Schepper, J
Fery, F
Hermans, MP
Keymeulen, B
Lauvaux, JP
Letiexhe, M
Mathieu, C
Nobels, FR
Rottiers, R
Scheen, A
Schmitt, H
Van Crombrugge, P
Van Gaal, L
Citation: M. Bex et al., Insulin lispro (Humalog((R))) in the treatment of diabetes mellitus: Overview of Belgian clinical data from global studies, ACT CLIN B, 54(5), 1999, pp. 241-245